Results | Latest & Breaking News on Results | Photos, Videos, Breaking Stories and Articles on Results

you are here: Home News

Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
Torrent Pharma Q1 PAT seen up 34.2% YoY to Rs 430.8 cr: KRChoksey
Torrent Pharma Q1 PAT seen up 10.8% YoY to Rs 355.7 cr: ICICI Direct
Torrent Pharma Q4 PAT may dip 1.9% YoY to Rs. 308 cr: Sharekhan
Torrent Pharma Q2 PAT seen up 8% YoY to Rs. 220.3 cr: Emkay
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
Torrent Pharmaceuticals Q4 PAT may dip 12.6% YoY to Rs. 199.3 cr: Kotak
Torrent Pharma Q3 PAT may dip 18.1% YoY to Rs. 199 cr: Sharekhan
Torrent Pharma Q3 PAT seen up 183.6% YoY to Rs. 164.5 cr: ICICI Direct
Credit Suisse expects strong Q3 quarter for Aurobindo, Torrent Pharma, Cadila
Torrent Pharma Q2 PAT may dip 5.4% YoY to Rs. 190 cr: HDFC Securities
Torrent Pharma Q2 PAT may dip 18.4% YoY to Rs. 166.5 cr: Sharekhan
Torrent Pharma Q2 PAT may dip 13.2% YoY to Rs. 177 cr: ICICI Direct
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
Torrent Pharmaceuticals Q1 PAT may dip 8.4% YoY to Rs. 172.2 cr: Kotak
Torrent Pharma Q4 PAT seen up 1.3% YoY to Rs. 210 cr: HDFC Securities
Torrent Pharmaceuticals Q4 PAT may dip 37.3% YoY to Rs. 129.3 cr: Edelweiss
Torrent Pharmaceuticals Q2 PAT seen up 13.9% YoY to Rs. 235.7 cr: Kotak
Torrent Pharma Q4 PAT may dip 8.3% to Rs 209.9 cr: ICICI Securities
Torrent Pharma Q3 PAT seen up 7.1% to Rs 220 cr: HDFC Securities
Torrent Pharma Q3 PAT seen up 15% to Rs 238 cr: ICICI Securities
Torrent Pharma Q2 profit seen down 52% on low operational income

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang

Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang

Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct

Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher

Torrent Pharma Q1 PAT seen up 34.2% YoY to Rs 430.8 cr: KRChoksey

Torrent Pharma Q1 PAT seen up 10.8% YoY to Rs 355.7 cr: ICICI Direct

Torrent Pharma Q4 PAT may dip 1.9% YoY to Rs. 308 cr: Sharekhan

Torrent Pharma Q2 PAT seen up 8% YoY to Rs. 220.3 cr: Emkay

Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show

Torrent Pharmaceuticals Q4 PAT may dip 12.6% YoY to Rs. 199.3 cr: Kotak

Torrent Pharma Q3 PAT may dip 18.1% YoY to Rs. 199 cr: Sharekhan

Torrent Pharma Q3 PAT seen up 183.6% YoY to Rs. 164.5 cr: ICICI Direct

Credit Suisse expects strong Q3 quarter for Aurobindo, Torrent Pharma, Cadila

Torrent Pharma Q2 PAT may dip 5.4% YoY to Rs. 190 cr: HDFC Securities

Torrent Pharma Q2 PAT may dip 18.4% YoY to Rs. 166.5 cr: Sharekhan

Torrent Pharma Q2 PAT may dip 13.2% YoY to Rs. 177 cr: ICICI Direct

Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz

Torrent Pharmaceuticals Q1 PAT may dip 8.4% YoY to Rs. 172.2 cr: Kotak

Torrent Pharma Q4 PAT seen up 1.3% YoY to Rs. 210 cr: HDFC Securities

Torrent Pharmaceuticals Q4 PAT may dip 37.3% YoY to Rs. 129.3 cr: Edelweiss

Torrent Pharmaceuticals Q2 PAT seen up 13.9% YoY to Rs. 235.7 cr: Kotak

Torrent Pharma Q4 PAT may dip 8.3% to Rs 209.9 cr: ICICI Securities

Torrent Pharma Q3 PAT seen up 7.1% to Rs 220 cr: HDFC Securities

Torrent Pharma Q3 PAT seen up 15% to Rs 238 cr: ICICI Securities

Torrent Pharma Q2 profit seen down 52% on low operational income